Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Repeated dose toxicity: dermal

Currently viewing:

Administrative data

Endpoint:
short-term repeated dose toxicity: dermal
Type of information:
experimental study
Adequacy of study:
supporting study
Study period:
1984
Reliability:
3 (not reliable)
Rationale for reliability incl. deficiencies:
other: Data from a preliminary study to select doses for a subsequent carcinogenicity study. Full range of parameters typical for repeat dose studies not examined

Data source

Referenceopen allclose all

Reference Type:
review article or handbook
Title:
Unnamed
Year:
2001
Reference Type:
study report
Title:
Unnamed
Report date:
1995

Materials and methods

Test guideline
Qualifier:
no guideline required
Principles of method if other than guideline:
To evaluate the toxic effects of repeated exposure to DEP by the dermal route and to select suitable dose levels for use in subsequent 2 year studies
GLP compliance:
no
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
Diethyl phthalate
EC Number:
201-550-6
EC Name:
Diethyl phthalate
Cas Number:
84-66-2
Molecular formula:
C12H14O4
IUPAC Name:
.
Details on test material:
- Name of test material (as cited in study report): diethyl phthalate
- Physical state: liquid
- Analytical purity:>99%
- Stability under test conditions: 2 weeks
- Storage condition of test material: stored in amber glass bottles protected from light at room temperature
- Other: The stability of the bulk chemical was monitored periodically using GC. No degradation of the bulk chemical occurred.

Test animals

Species:
mouse
Strain:
B6C3F1
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Simonsen Laboratories Inc Gilroy CA USA
- Age at study initiation: approximately 42 days
- Weight at study initiation: range of mean weights males: 20.6-21.4g; females: 15.9-16.5g
- Fasting period before study: N/A
- Housing: individual
- Diet (e.g. ad libitum): yes, NIH07 open formula meal (Zeigler Brothers, Gardeners PA USA
- Water (e.g. ad libitum): yes, by automatic system
- Acclimation period: 13 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 23-24 degrees C
- Humidity (%): 28-74%
- Air changes (per hr): 12
- Photoperiod (hrs dark / hrs light): 12h

IN-LIFE DATES: From: 1984-09-05 To: 1984-10-08

Administration / exposure

Type of coverage:
open
Vehicle:
unchanged (no vehicle)
Details on exposure:
TEST SITE
- Area of exposure: interscapular skin
- % coverage: not reported
- Type of wrap if used: N/A

REMOVAL OF TEST SUBSTANCE
- Washing (if done): not reported
- Time after start of exposure: not reported

TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 0, 12.5, 25, 50 or 100ul
- Concentration (if solution): 100% used as supplied
- Constant volume or concentration used: yes/no: constant concentration
- For solids, paste formed: N/A

USE OF RESTRAINERS FOR PREVENTING INGESTION: no
Analytical verification of doses or concentrations:
yes
Details on analytical verification of doses or concentrations:
Periodic analyses using reverse phase HPLC
Duration of treatment / exposure:
Ca 4 weeks
Frequency of treatment:
5 times /w (Monday -Friday)
Doses / concentrations
Remarks:
Doses / Concentrations:
0, 12.5, 25, 50 or 100ul
Basis:
nominal per unit area
No. of animals per sex per dose:
10 males & 10 females
Control animals:
yes, concurrent no treatment
Details on study design:

Animals randomly assigned to treatment groups using a computer generated randomisation procedure

Positive control:
No

Examinations

Observations and examinations performed and frequency:
CAGE SIDE OBSERVATIONS: Yes
- Time schedule: 2 X daily

DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: initially then weekly thereafter

DERMAL IRRITATION (if dermal study): No
- Time schedule for examinations:

BODY WEIGHT: Yes
- Time schedule for examinations: initially then weekly thereafter
Sacrifice and pathology:
GROSS PATHOLOGY: Yes
HISTOPATHOLOGY: Yes - complete histopathologic examinations conducted on all animals; Gross lesions, tissue masses and adrenal gland, brain, oesophagus, gall bladder , heart, kidney, lcolon, caecum, rectum, liver, lung, mammary gland, mandibular & mesenteric lymphnodes, nose, ovary, parathyroid gland, pituitary gland, prostate gland, salivary gland, seminal vesicles, skin ( site of application, control & other), duodenum, jejunum, ileum, spleen, sternum, stomach, testis, thymus, thyroid gland, trachea, urinary bladder & uterus
Other examinations:
No
Statistics:
Means & SDs & Williams or Dunnetts test

Results and discussion

Results of examinations

Clinical signs:
effects observed, treatment-related
Description (incidence and severity):
One female in the control group died. There were no clinical signs indicative of toxicity
Dermal irritation:
not examined
Mortality:
mortality observed, treatment-related
Description (incidence):
One female in the control group died. There were no clinical signs indicative of toxicity
Body weight and weight changes:
effects observed, treatment-related
Description (incidence and severity):
Final mean body weights of female mice given DEP were 5-7% heavier than controls
Food consumption and compound intake (if feeding study):
no effects observed
Food efficiency:
not examined
Water consumption and compound intake (if drinking water study):
not examined
Ophthalmological findings:
not examined
Haematological findings:
not examined
Clinical biochemistry findings:
not examined
Urinalysis findings:
not examined
Behaviour (functional findings):
not examined
Organ weight findings including organ / body weight ratios:
effects observed, treatment-related
Description (incidence and severity):
Absolute & relative liver weights were greater in females given 25 & 100 ul DEP than in controls.
Gross pathological findings:
no effects observed
Histopathological findings: non-neoplastic:
not specified
Histopathological findings: neoplastic:
not specified
Details on results:
CLINICAL SIGNS AND MORTALITY: No effect of treatment

BODY WEIGHT AND WEIGHT GAIN: No effect of treatment

FOOD CONSUMPTION: No effect of treatment

ORGAN WEIGHTS: Absolute & relative liver weights were greater in females given 25 & 100 ml DEP than in controls.

GROSS PATHOLOGY: No effect of treatment

HISTOPATHOLOGY: NON-NEOPLASTIC: No effect of treatment

OTHER FINDINGS: None

Effect levels

Dose descriptor:
NOAEL
Effect level:
12.5 other: ul
Based on:
test mat.
Sex:
male/female
Basis for effect level:
other: Increased liver weight (absolute & relative) in mice given 25 and 100 ul DEP.

Target system / organ toxicity

Critical effects observed:
not specified

Applicant's summary and conclusion

Conclusions:
Under the conditions of this study DEP applied neat to the skin of mice 5/7 days for 28 days the only effect was an increase in liver weight (absolute & relative) in those given 25 & 100 ul/31 & 123 mg. The NOAEL is considered to be 12.5 ul (15 mg).
Executive summary:

Under the conditions of this study DEP applied neat to the skin of mice 5/7 days for 28 days the only effect was an increase in liver weight (absolute & relative) in those given 25 & 100 ul/31 & 123 mg. The NOAEL is considered to be 12.5 ul (15 mg).